scispace - formally typeset
D

Dawn Swan

Researcher at University Hospital Galway

Publications -  25
Citations -  191

Dawn Swan is an academic researcher from University Hospital Galway. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 13 publications receiving 72 citations. Previous affiliations of Dawn Swan include University of Manchester & University Hospital Waterford.

Papers
More filters
Journal ArticleDOI

Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations.

TL;DR: The pathogenesis of thrombosis in multiple myeloma, its relation to some of the commonly used chemotherapeutic regimens, current risk stratification and the evidence supporting the different anticoagulants used as thromBoprophylaxis are discussed.
Journal ArticleDOI

Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma.

TL;DR: The effects cyclophosphamide has on the immune system is discussed, and how it can be used synergistically with other treatment modalities including the immunomodulatory agents, monoclonal antibodies and cellular therapies are discussed.
Journal ArticleDOI

Thrombosis in immune thrombocytopenia - current status and future perspectives.

TL;DR: In this paper, the authors discuss the epidemiology, aetiology and management of thrombotic events in patients with ITP, and consider the impact of ITP therapies on the increased risk of bleeding, in particular the use of Thrombopoietin-receptor agonists.
Journal ArticleDOI

Management of bleeding and procedures in patients on antiplatelet therapy.

TL;DR: In this paper, the authors provide updated guidance on the management of bleeding and surgery on antiplatelet drugs while stressing the need for further studies to provide evidence-based guidelines, although there is very limited evidence on how to manage urgent surgery in patients receiving these medications.
Journal ArticleDOI

The problem of under-diagnosis and over-diagnosis of pulmonary embolism.

TL;DR: Two issues of under- Diagnosis and over-diagnosis of PE in the current era are reviewed, including whether the chance finding of PE requires anticoagulation, especially when identified only at the subsegmental level are reviewed.